Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 2, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-000831.pdf 0001562180-23-000831.rtf 0001562180-23-000831.xls View HTML
February 2, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-000830.pdf 0001562180-23-000830.rtf 0001562180-23-000830.xls View HTML
January 30, 2023	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-23-019073.pdf 0001193125-23-019073.rtf 0001193125-23-019073.xls View HTML
January 20, 2023	SC 13G/A	An amendment to the SC 13G filing	0000093751-23-000018.pdf 0000093751-23-000018.rtf View HTML
January 9, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-004214.pdf 0001193125-23-004214.rtf 0001193125-23-004214.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 28, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-313116.pdf 0001193125-22-313116.rtf 0001193125-22-313116.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 19, 2022	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000895345-22-000827.pdf 0000895345-22-000827.rtf View HTML
December 15, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-305886.pdf 0001193125-22-305886.rtf 0001193125-22-305886.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
December 13, 2022	CT ORDER	CT ORDER	9999999997-22-004978.pdf
November 10, 2022	8-K	Report of unscheduled material events or corporate event	0001193125-22-282578.pdf 0001193125-22-282578.rtf 0001193125-22-282578.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax